Jessica M. Conway

Dr. Jessica M. Conway


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2018 in JCI Insight
Verified
Journal Article
Closed access
PDF file
RKRuian Ke
Ruian Ke
JCJessica M. Conway
Jessica M. Conway
DMDavid Michael M Margolis
David Michael M Margolis
APAlan S. Perelson
Alan S. Perelson
HIV eradication studies have focused on developing latency-reversing agents (LRAs). However, it is not understood how the rate of latent reservoir reduction is affected by different steps in the process of latency reversal. Furthermore, as current LRAs are host-directed, LRA treatment is likely to be intermittent to avoid host toxicities. Few careful studies of the serial effects of pulsatile LRA treatment have yet been done. This lack of clarity makes it difficult to evaluate the efficacy of candidate LRAs or predict long-term treatment outcomes. We constructed a mathematical model that describes the dynamics of latently infected cells under LRA treatment. Model analysis showed that, in addition to increasing the immune recognition and clearance of infected cells, the duration of HIV antigen expression (i.e., the period of vulnerability) plays an important role in determining the efficacy of LRAs, especially if effective clearance is achieved. Patients may benefit from pulsatile LRA exposures compared with continuous LRA exposures if the period of vulnerability is long and the clearance rate is high, both in the presence and absence of an LRA. Overall, the model framework serves as a useful tool to evaluate the efficacy and the rational design of LRAs and combination strategies.

12 June 2025 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
GRGianmarco Rasi
Gianmarco Rasi
EEElena Emili
Elena Emili
JCJessica M. Conway
Jessica M. Conway
NCNicola Cotugno
Nicola Cotugno
PPPaolo Palma
Paolo Palma
Combination antiretroviral therapy controls human immunodeficiency virus-1 (HIV) but cannot eradicate latent proviruses in immune cells, which reactivate upon treatment interruption. Anti-latency therapies like “shock-and-kill” are being developed but are yet to succeed due to the complexity of latency mechanisms. This review discusses recent advances in understanding HIV latency via mathematical modeling, covering key regulatory factors and models to predict latency reversal, highlighting gaps to guide future therapeutic approaches.

29 September 2026 in Viruses
Verified
Journal Article
Open access
PDF file
EMEllie Mainou
Ellie Mainou
SBStella Joan Berendam
Stella Joan Berendam
VOVeronica Obregon-Perko
Veronica Obregon-Perko
EREmilie Russell
Emilie Russell
CPCaroline Phan
Caroline Phan
JCJessica M. Conway
Jessica M. Conway
Viral dynamics of acute HIV infection and HIV rebound following suspension of antiretroviral therapy may be qualitatively similar but must differ given, for one, the development of adaptive immune responses. Understanding the differences between acute HIV infection and viral rebound dynamics in pediatric populations may provide insights into the mechanisms of viral control with potential implications for vaccine design and the development of effective targeted therapeutics for infants and children. Mathematical models have been a crucial tool to elucidate the complex processes driving viral infections within the host. Traditionally, acute HIV infection has been modeled with the standard model of viral dynamics, initially developed to explore viral decay during treatment, while viral rebound has necessitated extensions of that standard model to incorporate explicit immune responses. Previous efforts to fit these models to viral load data have underscored differences between the two infection stages, such as increased viral clearance rate and increased death rate of infected cells during rebound. However, these findings have been predicated on viral load measurements from disparate adult individuals. In this study, we aim to bridge this gap, in infants, by comparing the dynamics of acute infection and viral rebound within the same individuals by leveraging an infant non-human primate Simian/Human Immunodeficiency Virus (SHIV) infection model. Ten infant Rhesus macaques (RMs) orally challenged with SHIV.C.CH505.375H.dCT were given ART at 8 weeks post-infection. These infants were monitored for up to 60 weeks post-infection to ensure full suppression, then underwent analytic treatment interruption (ATI), resulting in viral rebound. We use the HIV standard viral dynamics model fit to viral load measurements in a nonlinear mixed effects framework to identify primary mechanisms distinguishing acute and rebound infection dynamics. We find that the primary difference between acute infection and viral rebound is the increased death rate of infected cells during the rebound phase. These findings allow us to formulate hypotheses about the effects of adaptive immune responses. Specifically, we propose that delayed viral rebound is characterized by a stronger CD8+ T-cell response. Our analysis provides evidence to support this notion and helps elucidate the observed outcomes.

14 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
LQLauren E. Quevillon
Lauren E. Quevillon
DHDavid Hughes
David Hughes
JCJessica M. Conway
Jessica M. Conway
Infectious disease outbreaks are a common constraint of group living organisms. Ants (Hymenoptera: Formicidae) live in large, dense colonies and are host to a diverse range of parasites and pathogens, facilitating the possibility of epidemic-induced collapse. However, the majority of parasites infecting ants require a period of development outside of the nest before they can transmit to their next ant host (‘ ex-nido ’ transmission) and the impact of these parasites on colony dynamics is unknown. Here we develop a mathematical model to assess ant colony dynamics in the presence of such parasites. We find that under field-realistic model conditions, such parasites are unlikely to cause the epidemic collapse of mature ant colonies, unless colony birth rate drops below 0.2328 ants/day. The preponderance of ex-nido transmitting parasites infecting ants and their limited epidemiological impact on colony dynamics may partly explain why collapsed ant colonies are rarely, if ever, observed in natural populations.